Xepi is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Biofrontera Inc.. The primary component is Ozenoxacin.
Product ID | 70621-103_3d5877f5-d12c-429e-9e31-e0e1abb58420 |
NDC | 70621-103 |
Product Type | Human Prescription Drug |
Proprietary Name | Xepi |
Generic Name | Ozenoxacin |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2019-12-19 |
Marketing Category | NDA / NDA |
Application Number | NDA208945 |
Labeler Name | Biofrontera Inc. |
Substance Name | OZENOXACIN |
Active Ingredient Strength | 10 mg/g |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-12-19 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA208945 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-12-19 |
Marketing Category | NDA |
Application Number | NDA208945 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-12-19 |
Ingredient | Strength |
---|---|
OZENOXACIN | 10 mg/g |
NDC | Brand Name | Generic Name |
---|---|---|
70363-011 | Xepi | ozenoxacin |
70621-103 | Xepi | ozenoxacin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XEPI 88767082 not registered Live/Pending |
FERRER INTERNACIONAL S.A. 2020-01-21 |
XEPI 87820029 not registered Live/Pending |
Medimetriks Pharmaceuticals, Inc. 2018-03-05 |
XEPI 86566661 not registered Dead/Abandoned |
Medimetriks Pharmaceuticals, Inc. 2015-03-17 |